KR20240046742A - 소분자 sting 길항제 - Google Patents

소분자 sting 길항제 Download PDF

Info

Publication number
KR20240046742A
KR20240046742A KR1020247007587A KR20247007587A KR20240046742A KR 20240046742 A KR20240046742 A KR 20240046742A KR 1020247007587 A KR1020247007587 A KR 1020247007587A KR 20247007587 A KR20247007587 A KR 20247007587A KR 20240046742 A KR20240046742 A KR 20240046742A
Authority
KR
South Korea
Prior art keywords
optionally substituted
benzo
dihydro
urea
thiazin
Prior art date
Application number
KR1020247007587A
Other languages
English (en)
Korean (ko)
Inventor
모날리 바네르지
수라브 바수
리테쉬 쿠마르 슈리바스타바
데이비드 카메론 프라이드
산딥 쿠마르 미디야
라지브 고쉬
다르멘드라 비. 야다브
아르준 수리아
Original Assignee
큐라데브 파마 프라이버트 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 큐라데브 파마 프라이버트 리미티드 filed Critical 큐라데브 파마 프라이버트 리미티드
Publication of KR20240046742A publication Critical patent/KR20240046742A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020247007587A 2021-08-11 2022-08-11 소분자 sting 길항제 KR20240046742A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB202111556 2021-08-11
IN202111036317 2021-08-11
IN202111036317 2021-08-11
GB2111556.3 2021-08-11
PCT/IB2022/057490 WO2023017451A1 (fr) 2021-08-11 2022-08-11 Antagonistes de sting à petites molécules

Publications (1)

Publication Number Publication Date
KR20240046742A true KR20240046742A (ko) 2024-04-09

Family

ID=83355624

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247007587A KR20240046742A (ko) 2021-08-11 2022-08-11 소분자 sting 길항제

Country Status (6)

Country Link
KR (1) KR20240046742A (fr)
AU (1) AU2022325543A1 (fr)
CA (1) CA3228528A1 (fr)
IL (1) IL310705A (fr)
TW (1) TW202321232A (fr)
WO (1) WO2023017451A1 (fr)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035298A1 (fr) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing-gum contenant des agents medicamenteux actifs
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
CN111132972A (zh) 2017-06-22 2020-05-08 克拉德夫制药有限公司 人sting的小分子调节剂
WO2018234805A1 (fr) * 2017-06-22 2018-12-27 Curadev Pharma Limited Modulateurs à petites molécules du sting humain
WO2019243823A1 (fr) * 2018-06-21 2019-12-26 Curadev Pharma Limited Modulateurs azahétérocycliques à petites molécules de sting humain
AU2021219370A1 (en) * 2020-02-12 2022-08-25 Curadev Pharma Pvt. Ltd. Small molecule STING antagonists

Also Published As

Publication number Publication date
AU2022325543A1 (en) 2024-02-15
TW202321232A (zh) 2023-06-01
WO2023017451A1 (fr) 2023-02-16
IL310705A (en) 2024-04-01
CA3228528A1 (fr) 2023-02-16

Similar Documents

Publication Publication Date Title
JP6321045B2 (ja) キナーゼ阻害剤としての複素環式アミド
KR101676391B1 (ko) 퇴행성 및 염증성 질병의 치료에 유용한 신규 화합물
KR20220141328A (ko) 소분자 sting 길항제
CA2870347C (fr) Derives de 3,4-dihydro-2h-pyrido[1,2-a]pyrazine-1,6-dione substitues pouvant etre utilises pour le traitement de (entre autres) la maladie d'alzheimer
JP2024037954A (ja) Ｒｉｐ１阻害化合物ならびにそれを作製および使用するための方法
JP5504252B2 (ja) ５−ｈｔ６アンタゴニストとしてのアリールスルホニルピラゾリンカルボキシアミジン誘導体
US11180490B2 (en) Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists
AU2008234017B2 (en) Imidazolidinone derivatives
GB2563642A (en) Small molecule modulators of human STING
JPH06145170A (ja) ヘテロ環式化合物、その製法及びこれを含有する高血圧及びうつ血性心不全治療用医薬組成物
TW201734005A (zh) 用於治療纖維化之新穎化合物及其醫藥組合物
US20170239237A1 (en) Pyrroloquinoline derivatives as 5-ht6 antagonists, preparation method and use thereof
JP2023553291A (ja) Ｔｒｐｍ３媒介性障害を治療するためのアリール誘導体
GB2572526A (en) Heterocyclic small molecule modulators of human STING
KR20240046742A (ko) 소분자 sting 길항제
JP7488768B2 (ja) ［１，２，４］トリアゾロ［４、３－ａ］ピラジン－８－オン誘導体
JP2001525398A (ja) 選択的β３アドレナリン作動性アゴニスト
KR20240046553A (ko) Sting 길항제로서의 소분자 우레아 유도체
CN118159535A (zh) 小分子sting拮抗剂
CA3212872A1 (fr) Derives d'indoline utilises en tant qu'inhibiteurs de ddr